Status:
COMPLETED
Placental Growth Factor as a Predictor of Adverse Pregnancy Outcomes in Preeclamptic Women
Lead Sponsor:
Johnbosco Ifunanya Nwafor
Conditions:
Pre-Eclampsia
Eligibility:
FEMALE
18-45 years
Brief Summary
Background: Preeclampsia is one of the leading causes of maternal and perinatal morbidity and mortality worldwide, and it affects 3% to 8% of all pregnancies. Maternal and perinatal morbidity and mort...
Detailed Description
INTRODUCTION Despite advances in care, preeclampsia remains a leading cause of maternal and perinatal morbidity and mortality worldwide and its syndromic nature makes diagnosis and management difficul...
Eligibility Criteria
Inclusion
- Singleton pregnancy
- Gestational age up to 34 weeks and above
Exclusion
- Multiple pregnancy
- Gestational age less than 34 weeks
Key Trial Info
Start Date :
October 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2019
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT04374604
Start Date
October 1 2018
End Date
July 31 2019
Last Update
May 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alex Ekwuueme Federal University Teaching Hospital
Abakaliki, Ebonyi State, Nigeria, 840001